If you need more lookups,
subscriptions start at $34 USD/month.
Ling-I Hsu Location
San Francisco, CA, US
Ling-I Hsu Work
Director, HTA Value and Evidence Oncology, Precision Medicine and Lung @ (June 2020 - Present)
Associate Director, Global Health Economics and Outcomes Research @ (November 2018 - June 2020)
Senior Manager, Global Health Economics and Outcomes Research @ (April 2018 - November 2018)
Associate Data Scientist, Real World Data Oncology, PHC Data Science @ (September 2016 - April 2018)
Senior Manager, Global Health Economics and Outcomes Research (Oncology) @ (July 2016 - September 2016)
Manager, Global Health Economics and Outcomes Research (Oncology) @ (April 2014 - July 2016)
Intern, US Health Economics and Outcomes (Oncology) @ (June 2013 - August 2013)
Ling-I Hsu Education
University of California, Berkeley
Doctor of Philosophy (Ph.D.) (Epidemiology)
Yale University
Master of Public Health (MPH) (Chronic Disease Epidemiology)
National Taiwan University
Bachelor's degree (Biochemical Science and Technology)
Ling-I Hsu Skills
Biostatistics
Clinical Research
Clinical Trials
Data Analysis
Epidemiology
Epidemiology/study design
Genetic Epidemiology
Health Economics
Literature Reviews
Oncology
Outcomes Research
Public Health
R
SAS
Statistical Modeling
Statistics
SAS, R programming
Genetics
Bioinformatics
Epidemiology/Study
Economics
R Programming
Matlab
Research
HEOR
Healthcare
Customer Service
Marketing
Ling-I Hsu Summary
Ling-I Hsu, based in San Francisco, CA, US, is currently a Director, HTA Value and Evidence Oncology, Precision Medicine and Lung at Pfizer. Ling-I Hsu brings experience from previous roles at Gilead Sciences, Genentech and AbbVie. Ling-I Hsu holds a Doctor of Philosophy (Ph.D.) in Epidemiology @ University of California, Berkeley. With a robust skill set that includes Biostatistics, Clinical Research, Clinical Trials, Data Analysis, Epidemiology and more. Ling-I Hsu has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Ling-I Hsu?
Find contact details for 700 million professionals.